First needle-free COVID-19 vaccine patch
If successful in further clinical trials an innovative, cost-effective COVID-19 vaccine patch could be available as early as 2025.
List view / Grid view
If successful in further clinical trials an innovative, cost-effective COVID-19 vaccine patch could be available as early as 2025.
The EMA will collaborate with other medicine regulatory bodies globally in a pilot programme to inspect sterile medicine manufacturers.